Highbridge Capital Management LLC Acquires Shares of 11,216 Thermo Fisher Scientific Inc. (TMO)

Highbridge Capital Management LLC acquired a new stake in Thermo Fisher Scientific Inc. (NYSE:TMO) during the third quarter, according to its most recent filing with the SEC. The firm acquired 11,216 shares of the medical research company’s stock, valued at approximately $2,122,000.

A number of other institutional investors and hedge funds have also recently made changes to their positions in the business. Covington Capital Management raised its stake in shares of Thermo Fisher Scientific by 0.9% in the 2nd quarter. Covington Capital Management now owns 2,144 shares of the medical research company’s stock valued at $374,000 after purchasing an additional 20 shares during the period. Investment Centers of America Inc. raised its stake in shares of Thermo Fisher Scientific by 1.6% in the 2nd quarter. Investment Centers of America Inc. now owns 1,317 shares of the medical research company’s stock valued at $230,000 after purchasing an additional 21 shares during the period. Fort Washington Investment Advisors Inc. OH raised its stake in shares of Thermo Fisher Scientific by 0.4% in the 2nd quarter. Fort Washington Investment Advisors Inc. OH now owns 6,250 shares of the medical research company’s stock valued at $1,090,000 after purchasing an additional 23 shares during the period. Bienville Capital Management LLC raised its stake in shares of Thermo Fisher Scientific by 1.6% in the 2nd quarter. Bienville Capital Management LLC now owns 1,687 shares of the medical research company’s stock valued at $295,000 after purchasing an additional 27 shares during the period. Finally, Savant Capital LLC raised its stake in shares of Thermo Fisher Scientific by 1.0% in the 2nd quarter. Savant Capital LLC now owns 2,793 shares of the medical research company’s stock valued at $487,000 after purchasing an additional 29 shares during the period. Hedge funds and other institutional investors own 86.05% of the company’s stock.

TMO has been the topic of a number of recent research reports. Zacks Investment Research raised Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $208.00 target price on the stock in a research report on Thursday, September 7th. Morgan Stanley reaffirmed an “overweight” rating and issued a $220.00 target price on shares of Thermo Fisher Scientific in a research report on Wednesday, September 6th. Cowen reaffirmed an “outperform” rating and issued a $220.00 target price (up previously from $200.00) on shares of Thermo Fisher Scientific in a research report on Sunday, September 10th. Leerink Swann reaffirmed a “buy” rating on shares of Thermo Fisher Scientific in a research report on Monday, October 30th. Finally, Deutsche Bank set a $226.00 price target on Thermo Fisher Scientific and gave the stock a “buy” rating in a report on Thursday, October 26th. One analyst has rated the stock with a hold rating and sixteen have given a buy rating to the company’s stock. Thermo Fisher Scientific has an average rating of “Buy” and an average target price of $205.21.

Shares of Thermo Fisher Scientific Inc. (NYSE:TMO) opened at $192.29 on Thursday. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.26 and a quick ratio of 0.81. Thermo Fisher Scientific Inc. has a 1 year low of $139.88 and a 1 year high of $201.20. The firm has a market cap of $77,749.00, a P/E ratio of 21.31, a PEG ratio of 1.78 and a beta of 1.06.

Thermo Fisher Scientific (NYSE:TMO) last announced its quarterly earnings data on Wednesday, October 25th. The medical research company reported $2.31 EPS for the quarter, beating the consensus estimate of $2.24 by $0.07. Thermo Fisher Scientific had a net margin of 11.73% and a return on equity of 15.94%. The business had revenue of $5.12 billion during the quarter, compared to the consensus estimate of $5.03 billion. During the same period in the previous year, the business earned $2.03 earnings per share. The company’s revenue was up 13.9% on a year-over-year basis. analysts predict that Thermo Fisher Scientific Inc. will post 9.36 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Monday, January 15th. Shareholders of record on Friday, December 15th will be given a dividend of $0.15 per share. The ex-dividend date of this dividend is Thursday, December 14th. This represents a $0.60 annualized dividend and a yield of 0.31%. Thermo Fisher Scientific’s dividend payout ratio is currently 10.19%.

In other news, CEO Marc N. Casper sold 50,000 shares of the company’s stock in a transaction on Friday, December 15th. The shares were sold at an average price of $191.74, for a total transaction of $9,587,000.00. Following the completion of the transaction, the chief executive officer now directly owns 302,577 shares in the company, valued at $58,016,113.98. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.49% of the stock is owned by insiders.

COPYRIGHT VIOLATION NOTICE: “Highbridge Capital Management LLC Acquires Shares of 11,216 Thermo Fisher Scientific Inc. (TMO)” was originally published by Community Financial News and is the sole property of of Community Financial News. If you are accessing this story on another website, it was illegally copied and republished in violation of United States & international trademark & copyright legislation. The correct version of this story can be accessed at https://www.com-unik.info/2017/12/21/highbridge-capital-management-llc-acquires-shares-of-11216-thermo-fisher-scientific-inc-tmo.html.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

What are top analysts saying about Thermo Fisher Scientific? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Thermo Fisher Scientific and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit